Correction: Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication (Journal of Vascular Surgery (2015) 61(3) (2S–41S.e1)(S0741521414022848)(10.1016/j.jvs.2014.12.009));Society for Vascular Surgery practice guidelines for atherosclerotic occlusive disease of the lower extremities: Management of asymptomatic disease and claudication

Journal of Vascular Surgery

Volumn 61, Issue 3, 2015, Pages 2S-41S.e1

  Conte, Michael S ^a   Pomposelli, Frank B ^b   Clair, Daniel G ^c   Geraghty, Patrick J ^d   McKinsey, James F ^e   Mills, Joseph L ^f   Moneta, Gregory L ^g   Murad, M Hassan ^h   Powell, Richard J ⁱ   Reed, Amy B ^j   Schanzer, Andres ^k   Sidawy, Anton N ^l  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b ST ELIZABETH'S MEDICAL CENTER   (United States)

^c LERNER RESEARCH INSTITUTE   (United States)

^d WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

^e MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^f UNIVERSITY OF ARIZONA   (United States)

^g OREGON HEALTH AND SCIENCE UNIVERSITY   (United States)

^h MAYO CLINIC   (United States)

ⁱ DARTMOUTH HITCHCOCK MEDICAL CENTER   (United States)

^j PENN STATE COLLEGE OF MEDICINE   (United States)

^k UNIVERSITY OF MASSACHUSETTS MEDICAL SCHOOL   (United States)

^l GEORGE WASHINGTON UNIVERSITY   (United States)

more..

Author keywords

[No Author keywords available]

Indexed keywords

AORTA DISEASE; ASYMPTOMATIC DISEASE; BYPASS SURGERY; CLINICAL DECISION MAKING; COMORBIDITY; DISEASE SEVERITY; ENDOVASCULAR SURGERY; EXERCISE; FUNCTIONAL DISEASE; GRAFT PATENCY; HUMAN; INTERMITTENT CLAUDICATION; LIMB ISCHEMIA; MEDICAL SOCIETY; PATIENT MONITORING; PATIENT SELECTION; PERIPHERAL OCCLUSIVE ARTERY DISEASE; PERSONALIZED MEDICINE; PRACTICE GUIDELINE; PRIORITY JOURNAL; REVASCULARIZATION; REVIEW; RISK BENEFIT ANALYSIS; RISK FACTOR; SAPHENOUS VEIN GRAFT; THERMODYNAMICS; ADVERSE EFFECTS; LEG; PATHOPHYSIOLOGY; PERIPHERAL ARTERIAL DISEASE; SEVERITY OF ILLNESS INDEX; STANDARDS; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGERY; VASCULARIZATION;

ASYMPTOMATIC DISEASES; ENDOVASCULAR PROCEDURES; HUMANS; INTERMITTENT CLAUDICATION; LOWER EXTREMITY; PATIENT SELECTION; PERIPHERAL ARTERIAL DISEASE; RISK FACTORS; SEVERITY OF ILLNESS INDEX; TREATMENT OUTCOME; VASCULAR PATENCY; VASCULAR SURGICAL PROCEDURES;

EID: 84923619188     PISSN: 07415214     EISSN: 10976809     Source Type: Journal    
DOI: 10.1016/j.jvs.2015.03.014     Document Type: Erratum

References (275)

1. F. Alahdab, A.T. Wang, T.A. Elraiyah, R.D. Malgor, A.Z. Rizvi, and M.A. Lane A systematic review for the screening for peripheral arterial disease in asymptomatic patients J Vasc Surg 61 2015 42S 53S
2. R.D. Malgor, F. Alalahdab, T.A. Elraiyah, A.Z. Rizvi, M.A. Lane, and L.J. Prokop A systematic review of treatment of intermittent claudication in the lower extremities J Vasc Surg 61 2015 54S 73S
3. P. Gloviczki, A.J. Comerota, M.C. Dalsing, B.G. Eklof, D.L. Gillespie, and M.L. Gloviczki The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum J Vasc Surg 53 5 Suppl 2011 2S 48S
4. B.M. Elliott Society for Vascular Surgery. Conflict of interest and the Society for Vascular Surgery J Vasc Surg 54 3 Suppl 2011 3 11S
5. F.G. Fowkes, D. Rudan, I. Rudan, V. Aboyans, J.O. Denenberg, and M.M. McDermott Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis Lancet 382 2013 1329 1340
6. M.H. Criqui, R.D. Langer, A. Fronek, H.S. Feigelson, M.R. Klauber, and T.J. McCann Mortality over a period of 10 years in patients with peripheral arterial disease N Engl J Med 326 1992 381 386
7. A.T. Hirsch, L. Hartman, R.J. Town, and B.A. Virnig National health care costs of peripheral arterial disease in the Medicare population Vasc Med 13 2008 209 215
8. E. Selvin, and T.P. Erlinger Prevalence of and risk factors for peripheral arterial disease in the United States: results from the National Health and Nutrition Examination Survey, 1999-2000 Circulation 110 2004 738 743
9. L. Norgren, W.R. Hiatt, J.A. Dormandy, M.R. Nehler, K.A. Harris, and F.G. Fowkes Inter-Society Consensus for the Management of Peripheral Arterial Disease (TASC II) J Vasc Surg 45 Suppl S 2007 S5 67
10. E.M. Mahoney, K. Wang, H.H. Keo, S. Duval, K.G. Smolderen, and D.J. Cohen Vascular hospitalization rates and costs in patients with peripheral artery disease in the United States Circ Cardiovasc Qual Outcomes 3 2010 642 651
11. A.T. Hirsch, M.H. Criqui, D. Treat-Jacobson, J.G. Regensteiner, M.A. Creager, and J.W. Olin Peripheral arterial disease detection, awareness, and treatment in primary care JAMA 286 2001 1317 1324
12. F.G. Fowkes, E. Housley, E.H. Cawood, C.C. Macintyre, C.V. Ruckley, and R.J. Prescott Edinburgh Artery Study: prevalence of asymptomatic and symptomatic peripheral arterial disease in the general population Int J Epidemiol 20 1991 384 392
13. T.R. Dawber, W.B. Kannel, N. Revotskie, J. Stokes 3rd, A. Kagan, and T. Gordon Some factors associated with the development of coronary heart disease: six years' follow-up experience in the Framingham study Am J Public Health Nations Health 49 1959 1349 1356
14. S.C. Smith Jr., R.V. Milani, D.K. Arnett, J.R. Crouse 3rd, M.M. McDermott, and P.M. Ridker Atherosclerotic Vascular Disease Conference: Writing Group II: risk factors Circulation 109 2004 2613 2616
15. J.M. Murabito, R.B. D'Agostino, H. Silbershatz, and W.F. Wilson Intermittent claudication. A risk profile from The Framingham Heart Study Circulation 96 1997 44 49
16. R. Zelis, D.T. Mason, E. Braunwald, and R.I. Levy Effects of hyperlipoproteinemias and their treatment on the peripheral circulation J Clin Invest 49 1970 1007 1015
17. N.P. Couch On the arterial consequences of smoking J Vasc Surg 3 1986 807 812
18. W.K. Al-Delaimy, A.T. Merchant, E.B. Rimm, W.C. Willett, M.J. Stampfer, and F.B. Hu Effect of type 2 diabetes and its duration on the risk of peripheral arterial disease among men Am J Med 116 2004 236 240
19. I.J. Kullo, K.R. Bailey, S.L. Kardia, T.H. Mosley Jr., E. Boerwinkle, and S.T. Turner Ethnic differences in peripheral arterial disease in the NHLBI Genetic Epidemiology Network of Arteriopathy (GENOA) study Vasc Med 8 2003 237 242
20. A.M. O'Hare, E. Vittinghoff, J. Hsia, and M.G. Shlipak Renal insufficiency and the risk of lower extremity peripheral arterial disease: results from the Heart and Estrogen/Progestin Replacement Study (HERS) J Am Soc Nephrol 15 2004 1046 1051
21. I.M. Graham, L.E. Daly, H.M. Refsum, K. Robinson, L.E. Brattstrom, and P.M. Ueland Plasma homocysteine as a risk factor for vascular disease. The European Concerted Action Project JAMA 277 1997 1775 1781
22. G.N. Welch, and J. Loscalzo Homocysteine and atherothrombosis N Engl J Med 338 1998 1042 1050
23. P.M. Ridker, J.E. Buring, J. Shih, M. Matias, and C.H. Hennekens Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women Circulation 98 1998 731 733
24. P. Ridker, M.J. Stampfer, and N. Rifai Novel risk factors for atherosclerosis: a comparison of C-reactive protein, fibrinogen, homocysteine, lipoprotein (a), and standard cholesterol screening as predictors of peripheral arterial disease JAMA 285 2001 2481 2485
25. A.M. Wilson, D.S. Shin, C. Weatherby, R.K. Harada, M.K. Ng, and N. Nair Asymmetric dimethylarginine correlates with measures of disease severity, major adverse cardiovascular events and all-cause mortality in patients with peripheral arterial disease Vasc Med 15 2010 267 274
26. A.M. Wilson, E. Kimura, R.K. Harada, N. Nair, B. Narasimhan, and X.Y. Meng Beta2-microglobulin as a biomarker in peripheral arterial disease: proteomic profiling and clinical studies Circulation 116 2007 1396 1403
27. W.R. Hiatt, A. Zakharyan, E.T. Fung, G. Crutcher, A. Smith, and C. Stanford A validated biomarker panel to identify peripheral artery disease Vasc Med 17 2012 386 393
28. M.M. Joosten, J.K. Pai, M.L. Bertoia, R.T. Gansevoort, S.J. Bakker, and J.P. Cooke β2-microglobulin, cystatin C, and creatinine and risk of symptomatic peripheral artery disease J Am Heart Assoc 3 2014 e000803
29. C.H. Cheng, Y.S. Chen, K.H. Shu, H.R. Chang, and M.C. Chou Higher serum levels of soluble intracellular cell adhesion molecule-1 and soluble vascular cell adhesion molecule predict peripheral artery disease in haemodialysis patients Nephrology (Carlton) 17 2012 718 724
30. A.W. Gardner, D.E. Parker, P.S. Montgomery, D. Sosnowska, A.I. Casanegra, and O.L. Esponda Impaired vascular endothelial growth factor a and inflammation in patients with peripheral artery disease Angiology 65 2014 683 690
31. A.D. Pradhan, N. Rifai, and P.M. Ridker Soluble intercellular adhesion molecule-1, soluble vascular adhesion molecule-1, and the development of symptomatic peripheral arterial disease in men Circulation 106 2002 820 825
32. M.M. McDermott, K. Liu, L. Ferrucci, L. Tian, J.M. Guralnik, and H. Tao Relation of interleukin-6 and vascular cellular adhesion molecule-1 levels to functional decline in patients with lower extremity peripheral arterial disease Am J Cardiol 107 2011 1392 1398
33. C.M. Robertson, F. Gerry, R. Fowkes, and J.F. Price Carotid intima-media thickness and the prediction of vascular events Vasc Med 17 2012 239 248
34. M.W. Lorenz, H.S. Markus, M.L. Bots, M. Rosvall, and M. Sitzer Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis Circulation 115 2007 459 467
35. J.A. Vita, and J.F. Keaney Jr. Endothelial function: a barometer for cardiovascular risk? Circulation 106 2002 640 642
36. N. Gokce, J.F. Keaney Jr., L.M. Hunter, M.T. Watkins, Z.S. Nedeljkovic, and J.O. Menzoian Predictive value of noninvasively determined endothelial dysfunction for long-term cardiovascular events in patients with peripheral vascular disease J Am Coll Cardiol 41 2003 1769 1775
37. M.C. Corretti, T.J. Anderson, E.J. Benjamin, D. Celermajer, F. Charbonneau, and M.A. Creager Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force J Am Coll Cardiol 39 2002 257 265
38. V. Aboyans, M.H. Criqui, P. Abraham, M.A. Allison, M.A. Creager, and C. Diehm Measurement and interpretation of the ankle-brachial index: a scientific statement from the American Heart Association Circulation 126 2012 2890 2909
39. J.S. Lin, C.M. Olson, E.S. Johnson, and E.P. Whitlock The ankle-brachial index for peripheral artery disease screening and cardiovascular disease prediction among asymptomatic adults: a systematic evidence review for the U.S. Preventive Services Task Force Ann Intern Med 159 2013 333 341
40. T. Sakurai, M. Matsushita, N. Nishikimi, and Y. Nimura Effect of walking distance on the change in ankle-brachial pressure index in patients with intermittent claudication Eur J Vasc Endovasc Surg 13 1997 486 490
41. E.K. Hoogeveen, A.J. Mackaay, P.J. Beks, P.J. Kostense, J.M. Dekker, and R.J. Heine Evaluation of the one-minute exercise test to detect peripheral arterial disease Eur J Clin Invest 38 2008 290 295
42. S.A. Carter Response of ankle systolic pressure to leg exercise in mild or questionable arterial disease N Engl J Med 287 1972 578 582
43. A.T. Hirsch, Z.J. Haskal, N.R. Hertzer, C.W. Bakal, M.A. Creager, and J.L. Halperin ACC/AHA 2005 Practice Guidelines for the management of patients with peripheral arterial disease (lower extremity, renal, mesenteric, and abdominal aortic): a collaborative report from the American Association for Vascular Surgery/Society for Vascular Surgery, Society for Cardiovascular Angiography and Interventions, Society for Vascular Medicine and Biology, Society of Interventional Radiology, and the ACC/AHA Task Force on Practice Guidelines (Writing Committee to Develop Guidelines for the Management of Patients With Peripheral Arterial Disease): endorsed by the American Association of Cardiovascular and Pulmonary Rehabilitation; National Heart, Lung, and Blood Institute; Society for Vascular Nursing; TransAtlantic Inter-Society Consensus; and Vascular Disease Foundation Circulation 113 2006 e463 654
44. R.B. Rutherford, D.H. Lowenstein, and M.F. Klein Combining segmental systolic pressures and plethysmography to diagnose arterial occlusive disease of the legs Am J Surg 138 1979 211 218
45. M.J. Koelemay, D. den Hartog, M.H. Prins, J.G. Kromhout, D.A. Legemate, and M.J. Jacobs Diagnosis of arterial disease of the lower extremities with duplex ultrasonography Br J Surg 83 1996 404 409
46. M. Romano, P.P. Mainenti, M. Imbriaco, B. Amato, K. Markabaoui, and O. Tamburrini Multidetector row CT angiography of the abdominal aorta and lower extremities in patients with peripheral arterial occlusive disease: diagnostic accuracy and interobserver agreement Eur J Radiol 50 2004 303 308
47. J. Menke, and J. Larsen Meta-analysis: accuracy of contrast-enhanced magnetic resonance angiography for assessing steno-occlusions in peripheral arterial disease Ann Intern Med 153 2010 325 334
48. V.A. Moyer U.S. Preventive Services Task Force Screening for peripheral artery disease and cardiovascular disease risk assessment with the ankle-brachial index in adults: U.S. Preventive Services Task Force recommendation statement Ann Intern Med 159 2013 342 348
49. F.G. Fowkes, G.D. Murray, I. Butcher, C.L. Heald, R.J. Lee, and L.E. Chambless Ankle brachial index combined with Framingham Risk Score to predict cardiovascular events and mortality: a meta-analysis JAMA 300 2008 197 208
50. M.H. Criqui, R.L. McClelland, M.M. McDermott, M.A. Allison, R.S. Blumenthal, and V. Aboyans The ankle-brachial index and incident cardiovascular events in the MESA (Multi-Ethnic Study of Atherosclerosis) J Am Coll Cardiol 56 2010 1506 1512
51. T.W. Rooke, A.T. Hirsch, S. Misra, A.N. Sidawy, J.A. Beckman, and L.K. Findeiss 2011 ACCF/AHA focused update of the guideline for the management of patients with peripheral artery disease (updating the 2005 guideline): a report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines: developed in collaboration with the Society for Cardiovascular Angiography and Interventions, Society of Interventional Radiology, Society for Vascular Medicine, and Society for Vascular Surgery J Vasc Surg 54 2011 e32 58
52. U.S.P.S.T. Force U.S. Preventive Services Task Force Screening for peripheral arterial disease: recommendation statement Am Fam Physician 73 2006 497 500
53. F.G. Fowkes, E. Housley, R.A. Riemersma, C.C. Macintyre, E.H. Cawood, and R.J. Prescott Smoking, lipids, glucose intolerance, and blood pressure as risk factors for peripheral atherosclerosis compared with ischemic heart disease in the Edinburgh Artery Study Am J Epidemiol 135 1992 331 340
54. B. Fowler, K. Jamrozik, P. Norman, Y. Allen, and E. Wilkinson Improving maximum walking distance in early peripheral arterial disease: randomised controlled trial Aust J Physiother 48 2002 269 275
55. F.G. Fowkes, J.F. Price, M.C. Stewart, I. Butcher, G.C. Leng, and A.C. Pell Aspirin for prevention of cardiovascular events in a general population screened for a low ankle brachial index: a randomized controlled trial JAMA 303 2010 841 848
56. Heart Protection Study Collaborative Group MRC/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial Lancet 360 2002 7 22
57. M.M. McDermott, J.M. Guralnik, P. Greenland, W.H. Pearce, M.H. Criqui, and K. Liu Statin use and leg functioning in patients with and without lower-extremity peripheral arterial disease Circulation 107 2003 757 761
58. N.J. Stone, J.G. Robinson, A.H. Lichtenstein, C.N. Bairey Merz, C.B. Blum, and R.H. Eckel 2013 ACC/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology/American Heart Association Task Force on Practice Guidelines Circulation 129 25 Suppl 2 2014 S1 45
59. M.M. McDermott, L. Fried, E. Simonsick, S. Ling, and J.M. Guralnik Asymptomatic peripheral arterial disease is independently associated with impaired lower extremity functioning: the women's health and aging study Circulation 101 2000 1007 1012
60. E.R. Mohler 3rd, W. Bundens, J. Denenberg, E. Medenilla, W.R. Hiatt, and M.H. Criqui Progression of asymptomatic peripheral artery disease over 1 year Vasc Med 17 2012 10 16
61. A. Singer, and C. Rob The fate of the claudicator Br Med J 2 1960 633 636
62. M.M. McDermott, P. Greenland, K. Liu, J.M. Guralnik, M.H. Criqui, and N.C. Dolan Leg symptoms in peripheral arterial disease: associated clinical characteristics and functional impairment JAMA 286 2001 1599 1606
63. M.M. McDermott, L. Tian, K. Liu, J.M. Guralnik, L. Ferrucci, and J. Tan Prognostic value of functional performance for mortality in patients with peripheral artery disease J Am Coll Cardiol 51 2008 1482 1489
64. M.M. McDermott, S. Mehta, and P. Greenland Exertional leg symptoms other than intermittent claudication are common in peripheral arterial disease Arch Intern Med 159 1999 387 392
65. K.W. Faulkner, A.K. House, and W.M. Castleden The effect of cessation of smoking on the accumulative survival rates of patients with symptomatic peripheral vascular disease Med J Aust 1 1983 217 219
66. R. Lassila, and M. Lepantalo Cigarette smoking and the outcome after lower limb arterial surgery Acta Chir Scand 154 1988 635 640
67. E.M. Willigendael, J.A. Teijink, M.L. Bartelink, R.J. Peters, H.R. Buller, and M.H. Prins Smoking and the patency of lower extremity bypass grafts: a meta-analysis J Vasc Surg 42 2005 67 74
68. Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S) Lancet 344 1994 1383 1389
69. Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels. The Long-Term Intervention with Pravastatin in Ischaemic Disease (LIPID) Study Group N Engl J Med 339 1998 1349 1357
70. F.M. Sacks, M.A. Pfeffer, L.A. Moye, J.L. Rouleau, J.D. Rutherford, and T.G. Cole The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels. Cholesterol and Recurrent Events Trial investigators N Engl J Med 335 1996 1001 1009
71. S.M. Grundy, J.I. Cleeman, C.N. Merz, H.B. Brewer Jr., L.T. Clark, and D.B. Hunninghake Implications of recent clinical trials for the National Cholesterol Education Program Adult Treatment Panel III guidelines Circulation 110 2004 227 239
72. E.R. Mohler 3rd, W.R. Hiatt, and M.A. Creager Cholesterol reduction with atorvastatin improves walking distance in patients with peripheral arterial disease Circulation 108 2003 1481 1486
73. S. Mondillo, P. Ballo, R. Barbati, F. Guerrini, T. Ammaturo, and E. Agricola Effects of simvastatin on walking performance and symptoms of intermittent claudication in hypercholesterolemic patients with peripheral vascular disease Am J Med 114 2003 359 364
74. T.P. Murphy, D.E. Cutlip, J.G. Regensteiner, E.R. Mohler, D.J. Cohen, and M.R. Reynolds Supervised exercise versus primary stenting for claudication resulting from aortoiliac peripheral artery disease: six-month outcomes from the claudication: exercise versus endoluminal revascularization (CLEVER) study Circulation 125 2012 130 139
75. T.A. Elhadd, R.T. Jung, R.W. Newton, P.A. Stonebridge, and J.J. Belch Incidence of asymptomatic peripheral arterial occlusive disease in diabetic patients attending a hospital clinic Adv Exp Med Biol 428 1997 45 48
76. B.M. Psaty, N.L. Smith, D.S. Siscovick, T.D. Koepsell, N.S. Weiss, and S.R. Heckbert Health outcomes associated with antihypertensive therapies used as first-line agents. A systematic review and meta-analysis JAMA 277 1997 739 745
77. K. Radack, and C. Deck Beta-adrenergic blocker therapy does not worsen intermittent claudication in subjects with peripheral arterial disease. A meta-analysis of randomized controlled trials Arch Intern Med 151 1991 1769 1776
78. F. Gustafsson, C. Torp-Pedersen, L. Kober, and P. Hildebrandt Effect of angiotensin converting enzyme inhibition after acute myocardial infarction in patients with arterial hypertension. TRACE Study Group, Trandolapril Cardiac Event J Hypertens 15 1997 793 798
79. M.A. Pfeffer, E. Braunwald, L.A. Moye, L. Basta, E.J. Brown Jr., and T.E. Cuddy Effect of captopril on mortality and morbidity in patients with left ventricular dysfunction after myocardial infarction. Results of the survival and ventricular enlargement trial. The SAVE Investigators N Engl J Med 327 1992 669 677
80. S. Yusuf, P. Sleight, J. Pogue, J. Bosch, R. Davies, and G. Dagenais Effects of an angiotensin-converting-enzyme inhibitor, ramipril, on cardiovascular events in high-risk patients. The Heart Outcomes Prevention Evaluation Study Investigators N Engl J Med 342 2000 145 153
81. Antithrombotic Trialists' Collaboration Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients BMJ 324 2002 71 86
82. CAPRIE Steering Committee A randomised, blinded, trial of clopidogrel versus aspirin in patients at risk of ischaemic events (CAPRIE). CAPRIE Steering Committee Lancet 348 1996 1329 1339
83. S. Yusuf, F. Zhao, S.R. Mehta, S. Chrolavicius, G. Tognoni, and K.K. Fox Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation N Engl J Med 345 2001 494 502
84. P.B. Berger, D.L. Bhatt, V. Fuster, P.G. Steg, K.A. Fox, and M. Shao Bleeding complications with dual antiplatelet therapy among patients with stable vascular disease or risk factors for vascular disease: results from the Clopidogrel for High Atherothrombotic Risk and Ischemic Stabilization, Management, and Avoidance (CHARISMA) trial Circulation 121 2010 2575 2583
85. Efficacy of oral anticoagulants compared with aspirin after infrainguinal bypass surgery (The Dutch Bypass Oral Anticoagulants or Aspirin Study): a randomised trial Lancet 355 2000 346 351
86. S.S. Anand, and S. Yusuf Oral anticoagulant therapy in patients with coronary artery disease: a meta-analysis JAMA 282 1999 2058 2067
87. Lowering blood homocysteine with folic acid based supplements: meta-analysis of randomised trials. Homocysteine Lowering Trialists' Collaboration BMJ 316 1998 894 898
88. VITATOPS Trial Study Group The VITATOPS (Vitamins to Prevent Stroke) Trial: rationale and design of an international, large, simple, randomised trial of homocysteine-lowering multivitamin therapy in patients with recent transient ischaemic attack or stroke Cerebrovasc Dis 13 2002 120 126
89. WENBIT - Western Norway B Vitamin Intervention Trial. Available at: clinicaltrials.gov/show/nct00354081. Accessed June 21, 2014.
90. S.C. Hood, D. Moher, and G.G. Barber Management of intermittent claudication with pentoxifylline: meta-analysis of randomized controlled trials CMAJ 155 1996 1053 1059
91. J.M. Porter, B.S. Cutler, B.Y. Lee, T. Reich, and F.A. Reichle Pentoxifylline efficacy in the treatment of intermittent claudication: multicenter controlled double-blind trial with objective assessment of chronic occlusive arterial disease patients Am Heart J 104 1982 66 72
92. P. Robless, D.P. Mikhailidis, and G.P. Stansby Cilostazol for peripheral arterial disease Cochrane Database Syst Rev 1 2008 CD003748
93. T. De Backer, R. Vander Stichele, P. Lehert, and L. Van Bortel Naftidrofuryl for intermittent claudication: meta-analysis based on individual patient data BMJ 338 2009 b603
94. T.L. de Backer, R. Vander Stichele, P. Lehert, and L. Van Bortel Naftidrofuryl for intermittent claudication Cochrane Database Syst Rev 12 1 2012 CD001368
95. K. Salhiyyah, E. Senanayake, M. Abdel-Hadi, A. Booth, and J.A. Michaels Pentoxifylline for intermittent claudication Cochrane Database Syst Rev 1 2012 CD005262
96. D.L. Dawson, B.S. Cutler, W.R. Hiatt, R.W. Hobson 2nd, J.D. Martin, and E.B. Bortey A comparison of cilostazol and pentoxifylline for treating intermittent claudication Am J Med 109 2000 523 530
97. Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus results of the HOPE study and MICRO-HOPE substudy. Heart Outcomes Prevention Evaluation Study Investigators Lancet 355 2000 253 259
98. A.A. Ahimastos, P.J. Walker, C. Askew, A. Leicht, E. Pappas, and P. Blombery Effect of ramipril on walking times and quality of life among patients with peripheral artery disease and intermittent claudication: a randomized controlled trial JAMA 309 2013 453 460
99. E.P. Brass, D. Koster, W.R. Hiatt, and A. Amato A systematic review and meta-analysis of propionyl-L-carnitine effects on exercise performance in patients with claudication Vasc Med 18 2013 3 12
100. C.L. Delaney, J.I. Spark, J. Thomas, Y.T. Wong, L.T. Chan, and M.D. Miller A systematic review to evaluate the effectiveness of carnitine supplementation in improving walking performance among individuals with intermittent claudication Atherosclerosis 229 2013 1 9
101. L. Watson, B. Ellis, and G.C. Leng Exercise for intermittent claudication Cochrane Database Syst Rev 4 2008 CD000990
102. A.W. Gardner, L. Forrester, and G.V. Smith Altered gait profile in subjects with peripheral arterial disease Vasc Med 6 2001 31 34
103. American College of Sports Medicine Position Stand and American Heart Association Recommendations for cardiovascular screening, staffing, and emergency policies at health/fitness facilities Med Sci Sports Exerc 30 1998 1009 1018
104. P.P. Aung, H.G. Maxwell, R.G. Jepson, J.F. Price, and G.C. Leng Lipid-lowering for peripheral arterial disease of the lower limb Cochrane Database Syst Rev 4 2007 CD000123
105. B. Hemmingsen, S.S. Lund, C. Gluud, A. Vaag, T.P. Almdal, and C. Hemmingsen Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus Cochrane Database Syst Rev 11 2013 CD008143
106. P.F. Wong, L.Y. Chong, D.P. Mikhailidis, P. Robless, and G. Stansby Antiplatelet agents for intermittent claudication Cochrane Database Syst Rev 11 2011 CD001272
107. J.W. Stevens, E. Simpson, S. Harnan, H. Squires, Y. Meng, and S. Thomas Systematic review of the efficacy of cilostazol, naftidrofuryl oxalate and pentoxifylline for the treatment of intermittent claudication Br J Surg 99 2012 1630 1638
108. A.W. Gardner, and E.T. Poehlman Exercise rehabilitation programs for the treatment of claudication pain. A meta-analysis JAMA 274 1995 975 980
109. W.R. Hiatt, E.E. Wolfel, R.H. Meier, and J.G. Regensteiner Superiority of treadmill walking exercise versus strength training for patients with peripheral arterial disease. Implications for the mechanism of the training response Circulation 90 1994 1866 1874
110. A.W. Gardner, P.S. Montgomery, W.R. Flinn, and L.I. Katzel The effect of exercise intensity on the response to exercise rehabilitation in patients with intermittent claudication J Vasc Surg 42 2005 702 709
111. S.A. Carter, E.R. Hamel, J.M. Paterson, C.J. Snow, and D. Mymin Walking ability and ankle systolic pressures: observations in patients with intermittent claudication in a short-term walking exercise program J Vasc Surg 10 1989 642 649
112. R.B. Patterson, B. Pinto, B. Marcus, A. Colucci, T. Braun, and M. Roberts Value of a supervised exercise program for the therapy of arterial claudication J Vasc Surg 25 1997 312 318 discussion: 318-9
113. M.J. Mouser, J.A. Zlabek, C.L. Ford, and M.A. Mathiason Community trial of home-based exercise therapy for intermittent claudication Vasc Med 14 2009 103 107
114. A.W. Gardner, D.E. Parker, P.S. Montgomery, K.J. Scott, and S.M. Blevins Efficacy of quantified home-based exercise and supervised exercise in patients with intermittent claudication: a randomized controlled trial Circulation 123 2011 491 498
115. A.A. Ahimastos, E.P. Pappas, P.G. Buttner, P.J. Walker, B.A. Kingwell, and J. Golledge A meta-analysis of the outcome of endovascular and noninvasive therapies in the treatment of intermittent claudication J Vasc Surg 54 2011 1511 1521
116. F.A. Frans, S. Bipat, J.A. Reekers, D.A. Legemate, and M.J. Koelemay SUPERvised exercise therapy or immediate PTA for intermittent claudication in patients with an iliac artery obstruction - a multicentre randomised controlled trial; SUPER study design and rationale Eur J Vasc Endovasc Surg 43 2012 466 471
117. S. Spronk, J.L. Bosch, P.T. den Hoed, H.F. Veen, P.M. Pattynama, and M.G. Hunink Intermittent claudication: clinical effectiveness of endovascular revascularization versus supervised hospital-based exercise training - randomized controlled trial Radiology 250 2009 586 595
118. L.M. Kruidenier, S.P. Nicolai, E.V. Rouwet, R.J. Peters, M.H. Prins, and J.A. Teijink Additional supervised exercise therapy after a percutaneous vascular intervention for peripheral arterial disease: a randomized clinical trial J Vasc Interv Radiol 22 2011 961 968
119. S.A. Badger, C.V. Soong, M.E. O'Donnell, C.A. Boreham, and K.E. McGuigan Benefits of a supervised exercise program after lower limb bypass surgery Vasc Endovascular Surg 41 2007 27 32
120. F. Lundgren, A.G. Dahllof, K. Lundholm, T. Schersten, and R. Volkmann Intermittent claudication - surgical reconstruction or physical training? A prospective randomized trial of treatment efficiency Ann Surg 209 1989 346 355
121. H.J. Fokkenrood, B.L. Bendermacher, G.J. Lauret, E.M. Willigendael, M.H. Prins, and J.A. Teijink Supervised exercise therapy versus non-supervised exercise therapy for intermittent claudication Cochrane Database Syst Rev 8 2013 CD005263
122. W.B. Kannel, J.J. Skinner Jr., M.J. Schwartz, and D. Shurtleff Intermittent claudication. Incidence in the Framingham Study Circulation 41 1970 875 883
123. J. Feinglass, W.J. McCarthy, R. Slavensky, L.M. Manheim, and G.J. Martin Effect of lower extremity blood pressure on physical functioning in patients who have intermittent claudication. The Chicago Claudication Outcomes Research Group J Vasc Surg 24 1996 503 511 discussion: 511-2
124. S.A. Myers, J.M. Johanning, N. Stergiou, T.G. Lynch, G.M. Longo, and Pipinos II Claudication distances and the Walking Impairment Questionnaire best describe the ambulatory limitations in patients with symptomatic peripheral arterial disease J Vasc Surg 47 2008 550 555
125. R.J. Mays, I.P. Casserly, W.M. Kohrt, P.M. Ho, W.R. Hiatt, and M.R. Nehler Assessment of functional status and quality of life in claudication J Vasc Surg 53 2011 1410 1421
126. G.C. Leng, B. Fowler, and E. Ernst Exercise for intermittent claudication Cochrane Database Syst Rev 2 2000 CD000990
127. J.G. Regensteiner, J.E. Ware Jr., W.J. McCarthy, P. Zhang, W.P. Forbes, and J. Heckman Effect of cilostazol on treadmill walking, community-based walking ability, and health-related quality of life in patients with intermittent claudication due to peripheral arterial disease: meta-analysis of six randomized controlled trials J Am Geriatr Soc 50 2002 1939 1946
128. A.E. McGlothlin, and R.J. Lewis Minimal clinically important difference: defining what really matters to patients JAMA 312 2014 1342 1343
129. M.E. Adriaensen, M.C. Kock, T. Stijnen, M.R. van Sambeek, H. van Urk, and P.M. Pattynama Peripheral arterial disease: therapeutic confidence of CT versus digital subtraction angiography and effects on additional imaging recommendations Radiology 233 2004 385 391
130. C. Catalano, F. Fraioli, A. Laghi, A. Napoli, M. Bezzi, and F. Pediconi Infrarenal aortic and lower-extremity arterial disease: diagnostic performance of multi-detector row CT angiography Radiology 231 2004 555 563
131. G.A. Holland, L. Dougherty, J.P. Carpenter, M.A. Golden, M. Gilfeather, and F. Slossman Breath-hold ultrafast three-dimensional gadolinium-enhanced MR angiography of the aorta and the renal and other visceral abdominal arteries AJR Am J Roentgenol 166 1996 971 981
132. S. Rosfors, M. Eriksson, N. Hoglund, and G. Johansson Duplex ultrasound in patients with suspected aorto-iliac occlusive disease Eur J Vasc Surg 7 1993 513 517
133. E. Ascher, N.A. Marks, A.P. Hingorani, R.W. Schutzer, and M. Mutyala Duplex-guided endovascular treatment for occlusive and stenotic lesions of the femoral-popliteal arterial segment: a comparative study in the first 253 cases J Vasc Surg 44 2006 1230 1237 discussion: 1237-8
134. G.R. Upchurch, J.B. Dimick, R.M. Wainess, J.L. Eliason, P.K. Henke, and J.A. Cowan Diffusion of new technology in health care: the case of aorto-iliac occlusive disease Surgery 136 2004 812 818
135. Galaria II, and M.G. Davies Percutaneous transluminal revascularization for iliac occlusive disease: long-term outcomes in TransAtlantic Inter-Society Consensus A and B lesions Ann Vasc Surg 19 2005 352 360
136. K. Schurmann, A. Mahnken, J. Meyer, P. Haage, K. Chalabi, and I. Peters Long-term results 10 years after iliac arterial stent placement Radiology 224 2002 731 738
137. J.L. Bosch, and M.G. Hunink Meta-analysis of the results of percutaneous transluminal angioplasty and stent placement for aortoiliac occlusive disease Radiology 204 1997 87 96
138. W. Ye, C.W. Liu, J.B. Ricco, K. Mani, R. Zeng, and J. Jiang Early and late outcomes of percutaneous treatment of TransAtlantic Inter-Society Consensus class C and D aorto-iliac lesions J Vasc Surg 53 2011 1728 1737
139. J.E. Indes, M.J. Pfaff, F. Farrokhyar, H. Brown, P. Hashim, and K. Cheung Clinical outcomes of 5358 patients undergoing direct open bypass or endovascular treatment for aortoiliac occlusive disease: a systematic review and meta-analysis J Endovasc Ther 20 2013 443 455
140. F.C. Carnevale, M. De Blas, S. Merino, J.M. Egana, and J.G. Caldas Percutaneous endovascular treatment of chronic iliac artery occlusion Cardiovasc Intervent Radiol 27 2004 447 452
141. B.P. Mwipatayi, S. Thomas, J. Wong, S.E. Temple, V. Vijayan, and M. Jackson A comparison of covered vs bare expandable stents for the treatment of aortoiliac occlusive disease J Vasc Surg 54 2011 1561 1570
142. E.M. Rzucidlo, R.J. Powell, R.M. Zwolak, M.F. Fillinger, D.B. Walsh, and M.L. Schermerhorn Early results of stent-grafting to treat diffuse aortoiliac occlusive disease J Vasc Surg 37 2003 1175 1180
143. C.P. Huded, P.P. Goodney, R.J. Powell, B.W. Nolan, E.M. Rzucidlo, and S.T. Simone The impact of adjunctive iliac stenting on femoral-femoral bypass in contemporary practice J Vasc Surg 55 2012 739 745
144. R.W. Chang, P.P. Goodney, J.H. Baek, B.W. Nolan, and E.M. Rzucidlo Long-term results of combined common femoral endarterectomy and iliac stenting/stent grafting for occlusive disease J Vasc Surg 48 2008 362 367
145. D.C. Brewster Clinical and anatomical considerations for surgery in aortoiliac disease and results of surgical treatment Circulation 83 2 Suppl 1991 I42 52
146. R.B. Rutherford Aortobifemoral bypass, the gold standard: technical considerations Semin Vasc Surg 7 1994 11 16
147. M.J. Hallisey, S.G. Meranze, B.C. Parker, K.S. Rholl, W.J. Miller, and B.T. Katzen Percutaneous transluminal angioplasty of the abdominal aorta J Vasc Interv Radiol 5 1994 679 687
148. P. Feugier, B. Toursarkissian, J.M. Chevalier, and J.P. Favre Endovascular treatment of isolated atherosclerotic stenosis of the infrarenal abdominal aorta: long-term outcome Ann Vasc Surg 17 2003 375 385
149. T.H. Kim, Y.G. Ko, U. Kim, J.S. Kim, D. Choi, and M.K. Hong Outcomes of endovascular treatment of chronic total occlusion of the infrarenal aorta J Vasc Surg 53 2011 1542 1549
150. M.A. Moise, J.A. Alvarez-Tostado, D.G. Clair, R.K. Greenberg, S.P. Lyden, and S.D. Srivastava Endovascular management of chronic infrarenal aortic occlusion J Endovasc Ther 16 2009 84 92
151. J. Lastovickova, and J.H. Peregrin Primary self-expandable nitinol stent placement in focal lesions of infrarenal abdominal aorta: long term results Cardiovasc Intervent Radiol 31 2008 43 48
152. R.C. Bruijnen, F.A. Grimme, A.D. Horsch, J.A. Van Oostayen, C.J. Zeebregts, and M.M. Reijnen Primary balloon expandable polytetrafluoroethylene-covered stenting of focal infrarenal aortic occlusive disease J Vasc Surg 55 2012 674 678
153. M.J. Sharafuddin, J.J. Hoballah, T.F. Kresowik, and W.J. Sharp Kissing stent reconstruction of the aortoiliac bifurcation Perspect Vasc Surg Endovasc Ther 20 2008 50 60
154. S. Yilmaz, T. Sindel, I. Golbasi, C. Turkay, A. Mete, and E. Luleci Aortoiliac kissing stents: long-term results and analysis of risk factors affecting patency J Endovasc Ther 13 2006 291 301
155. C.R. Burke, P.K. Henke, R. Hernandez, J.E. Rectenwald, V. Krishnamurthy, and M.J. Englesbe A contemporary comparison of aortofemoral bypass and aortoiliac stenting in the treatment of aortoiliac occlusive disease Ann Vasc Surg 24 2010 4 13
156. V.S. Kashyap, M.L. Pavkov, J.F. Bena, T.P. Sarac, P.J. O'Hara, and S.P. Lyden The management of severe aortoiliac occlusive disease: endovascular therapy rivals open reconstruction J Vasc Surg 48 2008 1451 1457 1457 e1-1457 e3
157. S.O. de Vries, and M.G. Hunink Results of aortic bifurcation grafts for aortoiliac occlusive disease: a meta-analysis J Vasc Surg 26 1997 558 569
158. M.D. Humphries, E. Armstrong, J. Laird, J. Paz, and W. Pevec Outcomes of covered versus bare-metal balloon-expandable stents for aortoiliac occlusive disease J Vasc Surg 60 2014 337 344
159. N.J. Ruggiero 2nd, and M.R. Jaff The current management of aortic, common iliac, and external iliac artery disease: basic data underlying clinical decision making Ann Vasc Surg 25 2011 990 1003
160. S. Ichihashi, W. Higashiura, H. Itoh, S. Sakaguchi, and K. Kichikawa Iliac artery stent placement relieves claudication in patients with iliac and superficial femoral artery lesions Cardiovasc Intervent Radiol 36 2013 623 628
161. Y. Soga, O. Iida, D. Kawasaki, Y. Yamauchi, K. Suzuki, and K. Hirano Contemporary outcomes after endovascular treatment for aorto-iliac artery disease Circ J 76 2012 2697 2704
162. B. Bechter-Hugl, J. Falkensammer, O. Gorny, A. Greiner, A. Chemelli, and G. Fraedrich The influence of gender on patency rates after iliac artery stenting J Vasc Surg 59 2014 1588 1596
163. R.F. Bonvini, A. Rastan, S. Sixt, U. Beschorner, E. Noory, and T. Schwarz Angioplasty and provisional stent treatment of common femoral artery lesions J Vasc Interv Radiol 24 2013 175 183
164. F. Baumann, M. Ruch, T. Willenberg, F. Dick, D.D. Do, and H.H. Keo Endovascular treatment of common femoral artery obstructions J Vasc Surg 53 2011 1000 1006
165. C.L. Paris, C.J. White, T.J. Collins, J.S. Jenkins, J.P. Reilly, and M.A. Grise Catheter-based therapy of common femoral artery atherosclerotic disease Vasc Med 16 2011 109 112
166. K.W. Chiu, R.S. Davies, P.G. Nightingale, A.W. Bradbury, and D.J. Adam Review of direct anatomical open surgical management of atherosclerotic aorto-iliac occlusive disease Eur J Vasc Endovasc Surg 39 2010 460 471
167. V. Jaquinandi, J. Picquet, J.L. Saumet, P. Benharash, G. Leftheriotis, and P. Abraham Functional assessment at the buttock level of the effect of aortobifemoral bypass surgery Ann Surg 247 2008 869 876
168. R.S. Juleff, O.W. Brown, M.M. McKain, J.L. Glover, and P.J. Bendick The influence of competitive flow on graft patency J Cardiovasc Surg (Torino) 33 1992 415 419
169. G.E. Pierce, M. Turrentine, S. Stringfield, J. Iliopoulos, C.A. Hardin, and A.S. Hermreck Evaluation of end-to-side v end-to-end proximal anastomosis in aortobifemoral bypass Arch Surg 117 1982 1580 1588
170. D.C. Brewster Current controversies in the management of aortoiliac occlusive disease J Vasc Surg 25 1997 365 379
171. J.M. Malone, W.S. Moore, and J. Goldstone Life expectancy following aortofemoral arterial grafting Surgery 81 1977 551 555
172. G.C. Morris Jr., E. Edwards, D.A. Cooley, E.S. Crawford, and M.E. De Bakey Surgical importance of profunda femoris artery. Analysis of 102 cases with combined aortoiliac and femoropopliteal occlusive disease treated by revascularization of deep femoral artery Arch Surg 82 1961 32 37
173. T. Inahara Evaluation of endarterectomy for aortoiliac and aortoiliofemoral occlusive disease Arch Surg 110 1975 1458 1464
174. R.R. Stoney, and L.M. Reilly Current therapy in vascular therapy C. Ernst, J.C. Stanley, Endarterectomy for aortoiliac occlusive disease 1987 BC Decker Philadelphia
175. J.B. Ricco, H. Probst French University Surgeons Association Long-term results of a multicenter randomized study on direct versus crossover bypass for unilateral iliac artery occlusive disease J Vasc Surg 47 2008 45 53 discussion: 53-4
176. C. Cham, K.A. Myers, D.F. Scott, T.J. Devine, and M.J. Denton Extraperitoneal unilateral iliac artery bypass for chronic lower limb ischaemia Aust N Z J Surg 58 1988 859 863
177. D. Melliere, P. Desgranges, G.W. de Wailly, F. Roudot-Thoraval, E. Allaire, and J.P. Becquemin Extensive unilateral iliofemoral occlusions: durability of four techniques of arterial reconstructions Vascular 12 2004 285 292
178. J.A. van der Vliet, D.M. Scharn, J.W. de Waard, R.M. Roumen, S.F. van Roye, and F.G. Buskens Unilateral vascular reconstruction for iliac obstructive disease J Vasc Surg 19 1994 610 614
179. J.W. York, B.L. Johnson, M. Cicchillo, S.M. Taylor, D.L. Cull, and C. Kalbaugh Aortobiiliac bypass to the distal external iliac artery versus aortobifemoral bypass: a matched cohort study Am Surg 79 2013 61 66
180. A.B. Reed, M.S. Conte, M.C. Donaldson, J.A. Mannick, A.D. Whittemore, and M. Belkin The impact of patient age and aortic size on the results of aortobifemoral bypass grafting J Vasc Surg 37 2003 1219 1225
181. J.B. Dimick, Cowan JA Jr., P.K. Henke, R.M. Wainess, S. Posner, and J.C. Stanley Hospital volume-related differences in aorto-bifemoral bypass operative mortality in the United States J Vasc Surg 37 2003 970 975
182. D.C. Brewster, and R.C. Darling Optimal methods of aortoiliac reconstruction Surgery 84 1978 739 748
183. R.J. Valentine, M.E. Hansen, S.I. Myers, A. Chervu, and G.P. Clagett The influence of sex and aortic size on late patency after aortofemoral revascularization in young adults J Vasc Surg 21 1995 296 305 discussion: 305-6
184. D.S. Sumner, and D.E. Strandness Jr. The hemodynamics of the femorofemoral shunt Surg Gynecol Obstet 134 1972 629 636
185. R.B. Rutherford, A. Patt, and W.H. Pearce Extra-anatomic bypass: a closer view J Vasc Surg 6 1987 437 446
186. M.A. Passman, L.M. Taylor, G.L. Moneta, J.M. Edwards, R.A. Yeager, and D.B. McConnell Comparison of axillofemoral and aortofemoral bypass for aortoiliac occlusive disease J Vasc Surg 23 1996 263 269 discussion: 269-71
187. J.R. Schneider, and J.F. Golan The role of extraanatomic bypass in the management of bilateral aortoiliac occlusive disease Semin Vasc Surg 7 1994 35 44
188. V. Jongkind, G.J. Akkersdijk, K.K. Yeung, and W. Wisselink A systematic review of endovascular treatment of extensive aortoiliac occlusive disease J Vasc Surg 52 2010 1376 1383
189. C.P. Twine, J. Coulston, A. Shandall, and A.D. McLain Angioplasty versus stenting for superficial femoral artery lesions Cochrane Database Syst Rev 2 2009 CD006767
190. J.H. Rogers, and J.R. Laird Overview of new technologies for lower extremity revascularization Circulation 116 2007 2072 2085
191. L.K. Lee, and K.C. Kent Infrainguinal occlusive disease: endovascular intervention is the first line therapy Adv Surg 42 2008 193 204
192. S.E. Wilson Trials of endovascular treatment for superficial femoral artery occlusive lesions: a call for medically managed control patients Ann Vasc Surg 24 2010 498 502
193. M.G. Hunink, J.B. Wong, M.C. Donaldson, M.F. Meyerovitz, and D.P. Harrington Patency results of percutaneous and surgical revascularization for femoropopliteal arterial disease Med Decis Making 14 1994 71 81
194. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder Nitinol stent implantation versus balloon angioplasty for lesions in the superficial femoral artery and proximal popliteal artery: twelve-month results from the RESILIENT randomized trial Circ Cardiovasc Interv 3 2010 267 276
195. P. Bergeron, J.J. Pinot, V. Poyen, H. Benichou, P. Khanoyan, and P. Rudondy Long-term results with the Palmaz stent in the superficial femoral artery J Endovasc Surg 2 1995 161 167
196. P.J. Geraghty, M.W. Mewissen, M.R. Jaff, and G.M. Ansel Three-year results of the VIBRANT trial of VIABAHN endoprosthesis versus bare nitinol stent implantation for complex superficial femoral artery occlusive disease J Vasc Surg 58 2013 386 395 e4
197. A.T. Kwa, K.K. Yeo, and J.R. Laird The role of stent-grafts for prevention and treatment of restenosis J Cardiovasc Surg (Torino) 51 2010 579 589
198. S.S. Ahn, and B. Concepcion Current status of atherectomy for peripheral arterial occlusive disease World J Surg 20 1996 635 643
199. G.K. Ambler, R. Radwan, P.D. Hayes, and C.P. Twine Atherectomy for peripheral arterial disease Cochrane Database Syst Rev 3 2014 CD006680
200. T. Zeller, A. Rastan, S. Sixt, U. Schwarzwalder, T. Schwarz, and U. Frank Long-term results after directional atherectomy of femoro-popliteal lesions J Am Coll Cardiol 48 2006 1573 1578
201. D. Scheinert, S. Duda, T. Zeller, H. Krankenberg, J. Ricke, and M. Bosiers The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty JACC Cardiovasc Interv 7 2014 10 19
202. G. Tepe, T. Zeller, T. Albrecht, S. Heller, U. Schwarzwalder, and J.P. Beregi Local delivery of paclitaxel to inhibit restenosis during angioplasty of the leg N Engl J Med 358 2008 689 699
203. M. Werk, S. Langner, B. Reinkensmeier, H.F. Boettcher, G. Tepe, and U. Dietz Inhibition of restenosis in femoropopliteal arteries: paclitaxel-coated versus uncoated balloon: femoral paclitaxel randomized pilot trial Circulation 118 2008 1358 1365
204. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, and H.B. Smouse Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results Circ Cardiovasc Interv 4 2011 495 504
205. A. Cioppa, E. Stabile, G. Popusoi, L. Salemme, L. Cota, and A. Pucciarelli Combined treatment of heavy calcified femoro-popliteal lesions using directional atherectomy and a paclitaxel coated balloon: one-year single centre clinical results Cardiovasc Revasc Med 13 2012 219 223
206. D.J. Hayes Jr., M.J. Dougherty, and K.D. Calligaro Management of flush superficial femoral artery occlusions with combined open femoral endarterectomy and endovascular femoral-popliteal angioplasty and stent-grafting Ann Vasc Surg 25 2011 559.e19 559.e23
207. T. Nishibe, Y. Kondo, A. Dardik, A. Muto, J. Koizumi, and M. Nishibe Hybrid surgical and endovascular therapy in multifocal peripheral TASC D lesions: up to three-year follow-up J Cardiovasc Surg (Torino) 50 2009 493 499
208. R.F. Bonvini, A. Rastan, S. Sixt, E. Noory, T. Schwarz, and U. Frank Endovascular treatment of common femoral artery disease: medium-term outcomes of 360 consecutive procedures J Am Coll Cardiol 58 2011 792 798
209. J.F. McKinsey, T. Zeller, K.J. Rocha-Singh, M.R. Jaff, and L.A. Garcia Lower extremity revascularization using directional atherectomy: 12-month prospective results of the DEFINITIVE LE Study JACC Cardiovasc Interv 7 2014 923 933
210. J.R. Laird, B.T. Katzen, D. Scheinert, J. Lammer, J. Carpenter, and M. Buchbinder Nitinol stent implantation vs. balloon angioplasty for lesions in the superficial femoral and proximal popliteal arteries of patients with claudication: three-year follow-up from the RESILIENT randomized trial J Endovasc Ther 19 2012 1 9
211. J.S. Matsumura, D. Yamanouchi, J.A. Goldstein, C.W. Pollock, M. Bosiers, and G.A. Schultz The United States StuDy for EvalUating EndovasculaR TreAtments of Lesions in the Superficial Femoral Artery and Proximal Popliteal By usIng the Protege EverfLex NitInol STent SYstem II (DURABILITY II) J Vasc Surg 58 2013 73 83.e1
212. M.D. Dake, G.M. Ansel, M.R. Jaff, T. Ohki, R.R. Saxon, and H.B. Smouse Sustained safety and effectiveness of paclitaxel-eluting stents for femoropopliteal lesions: 2-year follow-up from the Zilver PTX randomized and single-arm clinical studies J Am Coll Cardiol 61 2013 2417 2427
213. J Lammer, T Zeller, KA Hausegger, PJ Schaefer, M Gschwendtner, and S Mueller-Huelsbeck Heparin-bonded covered stents versus bare-metal stents for complex femoropopliteal artery lesions: the randomized VIASTAR trial (Viabahn endoprosthesis with PROPATEN bioactive surface [VIA] versus bare nitinol stent in the treatment of long lesions in superficial femoral artery occlusive disease) J Am Coll Cardiol 62 2013 1320 1327
214. P.C. Johnston, S.M. Vartanian, S.J. Runge, J.S. Hiramoto, C.M. Eichler, and C.D. Owens Risk factors for clinical failure after stent graft treatment for femoropopliteal occlusive disease J Vasc Surg 56 2012 998 1006 1007 e1; discussion 1006-7
215. F. Gorgani, A. Telis, N. Narakathu, M. LaBarbera, and A. Babaev Long-term outcomes of the Viabahn stent in the treatment of in-stent restenosis in the superficial femoral artery J Invasive Cardiol 25 2013 670 674
216. Tepe G, Laird J, Schneider P, Brodmann M, Krishnan P, Micari A, et al. Drug-coated balloon versus standard percutaneous transluminal angioplasty for the treatment of superficial femoral and/or popliteal peripheral artery disease: 12-month results from the IN.PACT SFA randomized trial [published online ahead of print December 3, 2014]. Circulation pii: CIRCULATIONAHA.114.011004.
217. C.S. Joels, J.W. York, C.A. Kalbaugh, D.L. Cull, and E.M. Langan Surgical implications of early failed endovascular intervention of the superficial femoral artery J Vasc Surg 47 2008 562 565
218. A.W. Bradbury, D.J. Adam, J. Bell, J.F. Forbes, F.G. Fowkes, and I. Gillespie Bypass versus Angioplasty in Severe Ischaemia of the Leg (BASIL) trial: an intention-to-treat analysis of amputation-free and overall survival in patients randomized to a bypass surgery-first or a balloon angioplasty-first revascularization strategy J Vasc Surg 51 5 Suppl 2010 5S 17S
219. D.M. Ihnat, S.T. Duong, Z.C. Taylor, L.R. Leon, J.L. Mills Sr., and K.R. Goshima Contemporary outcomes after superficial femoral artery angioplasty and stenting: the influence of TASC classification and runoff score J Vasc Surg 47 2008 967 974
220. M. Werner, A. Paetzold, U. Banning-Eichenseer, S. Scheinert, M. Piorkowski, and M. Ulrich Treatment of complex atherosclerotic femoropopliteal artery disease with a self-expanding interwoven nitinol stent: midterm results from the Leipzig SUPERA 500 registry EuroIntervention 10 2014 861 868
221. R.C. Lo, J. Darling, R.P. Bensley, K.A. Giles, S.E. Dahlberg, and A.D. Hamdan Outcomes following infrapopliteal angioplasty for critical limb ischemia J Vasc Surg 57 2013 1455 1463 discussion: 1463-4
222. M.M. McDermott, J.M. Guralnik, M.H. Criqui, L. Ferrucci, L. Zhao, and K. Liu Home-based walking exercise in peripheral artery disease: 12-month follow-up of the goals randomized trial J Am Heart Assoc 3 2014 e000711
223. J.G. Regensteiner, M.E. Hargarten, R.B. Rutherford, and W.R. Hiatt Functional benefits of peripheral vascular bypass surgery for patients with intermittent claudication Angiology 44 1993 1 10
224. E.S. van der Zaag, D.A. Legemate, M.H. Prins, J.A. Reekers, and M.J. Jacobs Angioplasty or bypass for superficial femoral artery disease? A randomised controlled trial Eur J Vasc Endovasc Surg 28 2004 132 137
225. G.L. Wolf, S.E. Wilson, A.P. Cross, R.H. Deupree, and W.B. Stason Surgery or balloon angioplasty for peripheral vascular disease: a randomized clinical trial. Principal investigators and their Associates of Veterans Administration Cooperative Study Number 199 J Vasc Interv Radiol 4 1993 639 648
226. F. Fowkes, and G.C. Leng Bypass surgery for chronic lower limb ischaemia Cochrane Database Syst Rev 2 2008 CD002000
227. J. Gelin, L. Jivegard, C. Taft, J. Karlsson, M. Sullivan, and A.G. Dahllof Treatment efficacy of intermittent claudication by surgical intervention, supervised physical exercise training compared to no treatment in unselected randomised patients I: one year results of functional and physiological improvements Eur J Vasc Endovasc Surg 22 2001 107 113
228. K. Koivunen, and H. Lukkarinen One-year prospective health-related quality-of-life outcomes in patients treated with conservative method, endovascular treatment or open surgery for symptomatic lower limb atherosclerotic disease Eur J Cardiovasc Nurs 7 2008 247 256
229. J.L. Mills Infrainguinal disease: surgical treatment (Table 113-1) J.L. Cronenwett, K.W. Johnston, Rutherford's Vascular Surgery 8th edition 2014 Elsevier Philadelphia 1768
230. A.F. AbuRahma, P.A. Robinson, and S.M. Holt Prospective controlled study of polytetrafluoroethylene versus saphenous vein in claudicant patients with bilateral above knee femoropopliteal bypasses Surgery 126 1999 594 601 discussion: 601-2
231. S. Zannetti, G.J. L'Italien, and R.P. Cambria Functional outcome after surgical treatment for intermittent claudication J Vasc Surg 24 1996 65 73
232. M.S. Conte, M. Belkin, M.C. Donaldson, P. Baum, J.A. Mannick, and A.D. Whittemore Femorotibial bypass for claudication: do results justify an aggressive approach? J Vasc Surg 21 1995 873 880 discussion: 880-1
233. G.A. Antoniou, N. Chalmers, G.S. Georgiadis, M.K. Lazarides, S.A. Antoniou, and F. Serracino-Inglott A meta-analysis of endovascular versus surgical reconstruction of femoropopliteal arterial disease J Vasc Surg 57 2013 242 253
234. F. Acin, J. de Haro, S. Bleda, C. Varela, and L. Esparza Primary nitinol stenting in femoropopliteal occlusive disease: a meta-analysis of randomized controlled trials J Endovasc Ther 19 2012 585 595
235. K. Katsanos, S. Spiliopoulos, N. Karunanithy, M. Krokidis, T. Sabharwal, and P. Taylor Bayesian network meta-analysis of nitinol stents, covered stents, drug-eluting stents, and drug-coated balloons in the femoropopliteal artery J Vasc Surg 59 2014 1123 1133 e8
236. J. Brown, A. Lethaby, H. Maxwell, A.J. Wawrzyniak, and M.H. Prins Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery (review) The Cochran Collaboration 2011 1 32
237. J.J. Belch, J. Dormandy, G.M. Biasi, M. Cairols, C. Diehm, and B. Eikelboom Results of the randomized, placebo-controlled clopidogrel and acetylsalicylic acid in bypass surgery for peripheral arterial disease (CASPAR) trial J Vasc Surg 52 2010 825 833 833 e1-e2
238. T.P. Sarac, T.S. Huber, M.R. Back, C.K. Ozaki, L.M. Carlton, and T.C. Flynn Warfarin improves the outcome of infrainguinal vein bypass grafting at high risk for failure J Vasc Surg 28 1998 446 457
239. M.R. Jackson, W.C. Johnson, W.O. Williford, R.J. Valentine, and G.P. Clagett The effect of anticoagulation therapy and graft selection on the ischemic consequences of femoropopliteal bypass graft occlusion: results from a multicenter randomized clinical trial J Vasc Surg 35 2002 292 298
240. L. Robertson, M.A. Ghouri, and F. Kovacs Antiplatelet and anticoagulant drugs for prevention of restenosis/reocclusion following peripheral endovascular treatment Cochrane Database Syst Rev 8 2012 CD002071
241. R. Koppensteiner, S. Spring, B.R. Amann-Vesti, T. Meier, T. Pfammatter, and V. Rousson Low-molecular-weight heaprin for prevention of restenosis after popliteal percutaneous transluminal angioplasty: a reandomized controlled trial J Vasc Surg 44 2006 1247 1253
242. O. Iida, S. Nanto, M. Uematsu, T. Morozumi, M. Kitakaze, and S. Nagata Cilostazol reduces restenosis after endovascular therapy in patients with femor0popliteal lesions J Vasc Surg 48 2008 144 149
243. H. Ishii, Y. Kumada, T. Toriyama, T. Aoyama, H. Takahashi, and M. Tanaka Effects of oral cilostazol 100 mg BID on long-term patency after percutaneous transluminal angioplasty in patients with femoropopliteal disease undergoing hemodialysis: a retrospective chart review in Japanese patients Clin Ther 32 2010 24 33
244. J. Brown, A. Lethaby, H. Maxwell, A.J. Wawrzyniak, and M.H. Prins Antiplatelet agents for preventing thrombosis after peripheral arterial bypass surgery Cochrane Database Syst Rev 4 2008 CD000535
245. A.J. Geraghty, and K. Welch Antithrombotic agents for preventing thrombosis after infrainguinal arterial bypass surgery Cochrane Database Syst Rev 6 2011 CD000536
246. A.H. Davies, A.J. Hawdon, M.R. Sydes, and S.G. Thompson Is duplex surveillance of value after leg vein bypass grafting? Principal results of the Vein Graft Surveillance Randomised Trial (VGST) Circulation 112 2005 1985 1991
247. A. Lundell, B. Lindblad, D. Bergqvist, and F. Hansen Femoropopliteal-crural graft patency is improved by an intensive surveillance program: a prospective randomized study J Vasc Surg 21 1995 26 33 discussion: 33-4
248. A.J. Avino, D.F. Bandyk, A.J. Gonsalves, B.L. Johnson, T.J. Black, and B.R. Zwiebel Surgical and endovascular intervention for infrainguinal vein graft stenosis J Vasc Surg 29 1999 60 70 discussion: 70-1
249. J.L. Mills, D.F. Bandyk, V. Gahtan, and G.E. Esses The origin of infrainguinal vein graft stenosis: a prospective study based on duplex surveillance J Vasc Surg 21 1995 16 22 discussion: 22-5
250. J.L. Mills Sr, C.L. Wixon, D.C. James, J. Devine, A. Westerband, and J.D. Hughes The natural history of intermediate and critical vein graft stenosis: recommendations for continued surveillance or repair J Vasc Surg 33 2001 273 278 discussion: 278-80
251. L.L. Nguyen, M.S. Conte, M.T. Menard, E.C. Gravereaux, D.K. Chew, and M.C. Donaldson Infrainguinal vein bypass graft revision: factors affecting long-term outcome J Vasc Surg 40 2004 916 923
252. A. Schanzer, N. Hevelone, C.D. Owens, M. Belkin, D.F. Bandyk, and A.W. Clowes Technical factors affecting autogenous vein graft failure: observations from a large multicenter trial J Vasc Surg 46 2007 1180 1190 discussion: 1190
253. G.J. Landry, G.L. Moneta, L.M. Taylor Jr., J.M. Edwards, R.A. Yeager, and J.M. Porter Long-term outcome of revised lower-extremity bypass grafts J Vasc Surg 35 2002 56 62 discussion: 62-3
254. L.L. Nguyen, G.L. Moneta, M.S. Conte, D.F. Bandyk, A.W. Clowes, and B.L. Seely Prospective multicenter study of quality of life before and after lower extremity vein bypass in 1404 patients with critical limb ischemia J Vasc Surg 44 2006 977 983 discussion: 983-4
255. P. Sobieszczyk, and A. Eisenhauer Management of patients after endovascular interventions for peripheral artery disease Circulation 128 2013 749 757
256. D.T. Baril, R.Y. Rhee, J. Kim, M.S. Makaroun, R.A. Chaer, and L.K. Marone Duplex criteria for determination of in-stent stenosis after angioplasty and stenting of the superficial femoral artery J Vasc Surg 49 2009 133 138 discussion: 139
257. M.W. Mewissen, E.V. Kinney, D.F. Bandyk, T. Reifsnyder, G.R. Seabrook, and E.O. Lipchik The role of duplex scanning versus angiography in predicting outcome after balloon angioplasty in the femoropopliteal artery J Vasc Surg 15 1992 860 865 discussion: 865-6
258. D. Sacks, M.L. Robinson, T.A. Summers, and D.L. Marinelli The value of duplex sonography after peripheral artery angioplasty in predicting subacute restenosis AJR Am J Roentgenol 162 1994 179 183
259. A.M. Spijkerboer, P.C. Nass, J.C. de Valois, Y. van der Graaf, B.C. Eikelboom, and W.P. Mali Evaluation of femoropopliteal arteries with duplex ultrasound after angioplasty. Can we predict results at one year? Eur J Vasc Endovasc Surg 12 1996 418 423
260. M.D. Humphries, W.C. Pevec, J.R. Laird, K.K. Yeo, N. Hedayati, and D.L. Dawson Early duplex scanning after infrainguinal endovascular therapy J Vasc Surg 53 2011 353 358
261. B.H. Gray, T.M. Sullivan, M.B. Childs, J.R. Young, and J.W. Olin High incidence of restenosis/reocclusion of stents in the percutaneous treatment of long-segment superficial femoral artery disease after suboptimal angioplasty J Vasc Surg 25 1997 74 83
262. A. Schmidt, M. Ulrich, B. Winkler, C. Klaeffling, Y. Bausback, and S. Braunlich Angiographic patency and clinical outcome after balloon-angioplasty for extensive infrapopliteal arterial disease Catheter Cardiovasc Interv 76 2010 1047 1054
263. A.V. Tielbeek, E. Rietjens, J. Buth, D. Vroegindeweij, and F.P. Schol The value of duplex surveillance after endovascular intervention for femoropopliteal obstructive disease Eur J Vasc Endovasc Surg 12 1996 145 150
264. A.M. Spijkerboer, P.C. Nass, J.C. de Valois, B.C. Eikelboom, T.T. Overtoom, and F.J. Beek Iliac artery stenoses after percutaneous transluminal angioplasty: follow-up with duplex ultrasonography J Vasc Surg 23 1996 691 697
265. T.D. Bui, J.L. Mills Sr., D.M. Ihnat, A.C. Gruessner, K.R. Goshima, and J.D. Hughes The natural history of duplex-detected stenosis after femoropopliteal endovascular therapy suggests questionable clinical utility of routine duplex surveillance J Vasc Surg 55 2012 346 352
266. K.J. Stewart, W.R. Hiatt, J.G. Regensteiner, and A.T. Hirsch Exercise training for claudication N Engl J Med 347 2002 1941 1951
267. E. Criado, S.J. Burnham, E.A. Tinsley Jr., G. Johnson Jr., and B.A. Keagy Femorofemoral bypass graft: analysis of patency and factors influencing long-term outcome J Vasc Surg 18 1993 495 504 discussion: 504-5
268. S. Mii, D. Eguchi, T. Takenaka, S. Maehara, S. Tomisaki, and H. Sakata Role of femorofemoral crossover bypass grafting for unilateral iliac atherosclerotic disease: a comparative evaluation with anatomic bypass Surg Today 35 2005 453 458
269. G.S. Muradin, J.L. Bosch, T. Stijnen, and M.G. Hunink Balloon dilation and stent implantation for treatment of femoropopliteal arterial disease: meta-analysis Radiology 221 2001 137 145
270. M. Schillinger, S. Sabeti, C. Loewe, P. Dick, J. Amighi, and W. Mlekusch Balloon angioplasty versus implantation of nitinol stents in the superficial femoral artery N Engl J Med 354 2006 1879 1888
271. J. Kedora, S. Hohmann, W. Garrett, C. Munschaur, B. Theune, and D. Gable Randomized comparison of percutaneous Viabahn stent grafts vs prosthetic femoral-popliteal bypass in the treatment of superficial femoral arterial occlusive disease J Vasc Surg 45 2007 10 16 discussion: 16
272. Shackles C, Rundback JH, Herman K, David Y, Barkarma R. Above and below knee femoropopliteal VIABAHN [published online ahead of print September 9, 2014]. Catheter Cardiovasc Interv. http://dx.doi.org/10.1002/ccd.25666.
273. C.E. Pereira, M. Albers, M. Romiti, F.C. Brochado-Neto, and C.A. Pereira Meta-analysis of femoropopliteal bypass grafts for lower extremity arterial insufficiency J Vasc Surg 44 2006 510 517
274. P. Klinkert, A. Schepers, D.H. Burger, J.H. van Bockel, and P.J. Breslau Vein versus polytetrafluoroethylene in above-knee femoropopliteal bypass grafting: five-year results of a randomized controlled trial J Vasc Surg 37 2003 149 155
275. B.I. Robinson, J.P. Fletcher, P. Tomlinson, R.D. Allen, S.J. Hazelton, and A.J. Richardson A prospective randomized multicentre comparison of expanded polytetrafluoroethylene and gelatin-sealed knitted Dacron grafts for femoropopliteal bypass Cardiovasc Surg 7 1999 214 218